In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...